[1]
Yelisetti, U.M. et al. 2026. Curcumin Nanoformulations For Neurological and Psychiatric Disorders: Delivery Strategies, Preclinical Evidence and Translational Prospects. Adolescência e Saúde. (Nov. 2026), 8–21.